Install
Vaccines & Immunology
mRNA platforms, boosters, monoclonals, and immune‑system science.
- 18 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Vaccines & Immunology
The map: modality by tumour type
5+ hour, 29+ min ago (1581+ words) 12 October 2026 | Monday | News There is one more reason to read the sessions closely. Topline press releases have already told markets that most of these trials hit their endpoints. What they have not said is by how much. Every entry below…...
RNA Sensor MDA5 Emerges as a Surprising Ally of Tumors Against Immune Attack
12+ min ago (590+ words) Bioengineer.org...
Automated lipid nanoparticle platform promises faster RNA therapy design
28+ min ago (550+ words) Bioengineer.org...
Can The Public Trust The Numbers If They Can’t Understand Them?; A Research Paper Summarization on Covid 19 Vaccination Data Visualization Issues
5+ hour, 10+ min ago (375+ words) Fig 1. Fig 6 (Ismail et al., 2022, p.305) from the research paper shows a non effective dashboard, it lacked interactivity and thus was not as useful. Some of the charts used color without any clear purpose. For example two charts (Fig.2 & Fig 3) have…...
Moderna and CSIRO target biosecurity
4+ day, 3+ hour ago (327+ words) Moderna Technology Centre in Melbourne is the Southern Hemisphere’s first end-to-end mRNA manufacturing facility. Image: Moderna Moderna general manager for Australia and New Zealand Dr Carolyn Tucek-Szabo said the partnership represented a significant investment in Australia’s biosecurity capability. “Together with…...
Sliced Tumors Keep Their Immune System Alive, Opening a New Window on Bladder Cancer Drug Testing
11+ hour, 1+ min ago (86+ words) Researchers at Lund University have shown that precision-cut slices of bladder tumors keep their immune cells alive and functional for up to six days, enabling ex vivo drug testing that reproduced clinical response rates to the checkpoint inhibitor nivolumab. Subject…...
Virus-driven lymphoma cells rely on a mitochondrial enzyme duo to dodge cell death
13+ hour, 29+ min ago (616+ words) Bioengineer.org...
Demoted CD4+ T-cell activity resulted from CTNNB1 mutations resists lenvatinib plus anti-PD1 in HCC
1+ day, 4+ hour ago (182+ words) Cell Death & Disease (2026) Cite this article We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by…...
Epithelial–mesenchymal transition in immune escape and immunotherapy resistance of lung cancer
2+ day, 4+ hour ago (131+ words) npj Precision Oncology (2026) Cite this article We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by…...
RNA Cap Modification Emerges as a Switch That Governs Tumor Response to Radiotherapy
23+ hour, 22+ min ago (71+ words) A new study shows that the RNA cap-modifying enzyme PCIF1 drives tumor growth and radioresistance, and that removing its m6Am mark on MSH2 activates the cGAS-STING immune pathway to boost radiotherapy and anti-PD-1 therapy. Subject of Research: PCIF1-mediated m6Am modification of MSH2 mRNA in tumor…...